(Acyloxy)alkyl Carbamates as Novel Bioreversible Prodrugs for Amines: Increased Permeation through Biological Membranes

Journal of Medicinal Chemistry

Volumn 31, Issue 2, 1988, Pages 318-322

  Alexander, Jose ^a   Cargill, Robyn ^a   Michelson, Stuart R ^b   Schwam, Harvey ^b  

^a Interx Research Corp in Lawrence   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETAXOLOL; N ACETOXYMETHOXYCARBONYLATENOLOL; N ACETOXYMETHOXYCARBONYLBETAXOLOL; N ACETOXYMETHOXYCARBONYLPINDOLOL; N ACETOXYMETHOXYCARBONYLPROPRANOLOL; N ACETOXYMETHOXYCARBONYLTIMOLOL; PINDOLOL; PRODRUG; PROPRANOLOL; TIMOLOL; UNCLASSIFIED DRUG;

ANIMAL CELL; BIOAVAILABILITY; BIOLOGICAL MODEL; DRUG DEVELOPMENT; NONHUMAN; RABBIT; RAT; SKIN PENETRATION;

EID: 0000658454     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00397a008     Document Type: Article

References (48)

1. Yalkowsky, S. H.; Morozowich, W. In Drug Design; Ariéns, E. J., Ed.; Academic: New York, 1980; Vol. IX, p 121.
2. Higuchi, T. In Design of Biopharmaceutical Properties through Prodrugs and Analogs; Roch, E. B., Ed., American Pharmaceutical Association; Washington, DC, 1977; p 409.
3. Bodor, N. In Optimization of Drug Delivery; Alfred Benzon Symposium 17; Bundgaard, H., Hansen, A. B., Kofod, H., Eds.; Munskgaard: Copenhagen, 1982; p 156.
4. Stella, V. J.; Himmelstein, K. J. J. Med. Chem. 1980, 23, 1275 and references cited therein.
5. Ferres, H. Med. Actual. 1983, 19, 499.
6. Ferres, H. Chem. Ind. (London) 1980, 435.
7. Pitman, I. H. Med. Res. Rev. 1981, 1, 189.
8. Bundgaard, H. In Optimization of Drug Delivery; Alfred Benzon Symposium 17; Bundgaard, H., Hansen, A. B., Kofod, H., Eds.; Munksgaard: Copenhagen, 1982; p 178.
9. Kyncl, J. J.; Minard, F. N.; Jones, P. H. Adv. Biosci. 1979, 20, 369.
10. Caldwell, H. C.; Adams, H. J.; Jones, R. G.; Mann, W. A.; Dittert, L. W.; Chong, C. W.; Swintosky, J. V. J. Pharm. Sci. 1971, 60, 1810.
11. Cavallito, C., U.S. Patent 2 923, 661, 1960.
12. Smyth, R. D.; Pfeffer, M.; Van Harken, D. R.; Cohen, A.; Hottendorf, G. H. Antimicrob. Agents Chemother. 1981, 19, 1004.
13. Johansen, M.; Bundgaard, H. J. Pharm. Sci. 1983, 72, 1294.
14. Gottstein, W. J.; Minor, W. F.; Cheney, L. C. J. Am. Chem. Soc. 1959, 81, 1198.
15. Bundgaard, H.; Johansen, M. J. Pharm. Sci. 1980, 69, 44.
16. Bansal, P. C.; Pitman, I. H.; Higuchi, T. J. Pharm. Sci. 1981, 70, 855.
17. Bodor, N.; Kaminsky, J. J.; Selk, S. J. Med. Chem. 1980, 23, 469.
18. Firestone, R. A.; Pisano, J. M.; Falck, J. R.; McPhaul, M. M.; Kreiger, M. J. Med. Chem. 1984, 27, 1037.
19. Kupchan, S. M.; Icenberg, A. C. J. Med. Chem. 1967, 10, 960.
20. Verbiscar, A. J.; Abood, L. G. J. Med. Chem. 1970, 13, 1176.
21. Wilson, I. B.; Harrison, S.; Ginsburg, S. J. Biol. Chem. 1961, 236, 1498.
22. O'Brien, R. D.; Hilton, B. D.; Gilmour, L. Mol. Pharmacol. 1966, 2, 593.
23. Torsten Olsson, O. A.; Svenson, L.-A. Pharm. Res. 1984, 1, 11.
24. Svenson, L.-A.; Olsson, T.; Tegnér, K.; Tunek, A. Abstract of Papers, 186th National Meeting of the American Chemical Society, Washington, DC; American Chemical Society: Washington, DC, 1983; MEDI 18.
25. Erlanger, B. F.; Edel, F. Biochemistry 1964, 3, 346.
26. Verbiscar, A. J.; U.S. Patent 3742022, 1973; 3876661, 1975.
27. Shih, C. Diss. Abstr. Int., B 1980, 41, 1774.
28. Alexander, J. U.S. Patent Appl. 507316, 1983 and 327156, 1984.
29. Alexander, J. European Pat. Appl. EP167.451 and EP 130, 119.
30. Alexander, J. Chem. Abstr. 1986, 104, 168201 and 1985, 103, 196097z.
31. Weinstock, L. M.; Tull, R. J.; Mulvey, D. M. Can. Pat. 965, 787, 1975;
32. Weinstock, L. M.; Tull, R. J.; Mulvey, D. M. Chem. Abstr. 1975, 83, 97269u.
33. Welsh, L. H. J. Am. Chem. Soc. 1947, 69, 128.
34. Fodor, G.; Kiss, J. J. Am. Chem. Soc., 1950, 72, 3495.
35. Avram, M.; Mateescu, GH. D. In Infrared Spectroscopy, Interscience, New York, 1972; p 467.
36. Nelson, W.; Walker, R. B. Res. Commun. Chem. Pathol. Pharmacol. 1978, 22, 435.
37. Jackman, L. M.; Sternhall, S. In Applications of Nuclear Magnetic Resonance Spectroscopy in Organic Chemistry, Pergamon: Oxford, 1969; p 176.
38. Martz, J. T.; Senet, J.-P.; Piteau, M.; Malfroot, T. J. Org. Chem. 1984, 49, 2081.
39. Gogate, U. S. Ph.D. Dissertation, University of Kansas, 1987.
40. Gogate, U. S.; Repta, A. J.; Alexander, J. Int. J. Pharm., in press
41. Cargill, R.; Engle, K.; Rork, G.; Caldwell, L. J. Pharm. Res. 1986, 3, 225.
42. Schoenwald, R. D.; Huang, H.-S. J. Pharm. Sci. 1983, 72, 1266.
43. Betageri, G. V.; Rogers, J. A. Int. J. Pharm. 1987, 36, 165.
44. Shereff, R. H.; Harwell, W.; Lieberman, P.; Rosenberg, E. W.; Robinson, H. J. Allergy Clin. Immunol. 1983, 72, 328.
45. Lamkin, N.; Lieberman, P.; Shereff, R.; Rosenberg, E. W.; Robinson, H. J. Allergy Clin. Immunol. 1976, 57, 449.
46. Edelhauser, H. F.; Hoffert, J. R.; Fromm, P. O. Invest. Ophthalmol. 1965, 4, 290.
47. O'Brien, W. J.; Edelhauser, H. F.; Invest, Ophthalmol. Visual Sci. 1977, 16, 1093;
48. Schownwald, R. D.; Ward, R. L. J. Pharm. Sci. 1978, 67, 786.